Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19
Marina Wainstein(The University of Queensland), Barbara Wanjiru Citarella(University of Oxford), Clotilde Allavena(Centre Hospitalier Universitaire de Nantes), Eka Airlangga, Rita Vieira Alves(University of Oxford), Nurul Najmee Abdulkadir, Lilia Rizo‐Topete, João Alves, Takako Akimoto, Senthilkumar Alegesan, Ali Ait Hssain, Shingo Adachi(Angkor Hospital for Children), Saleh Al Ageel, Nicholas Spyrison(The University of Queensland), Beatrice Alex(Imperial College London), David W. Johnson(Hennepin County), Younes Ait Tamlihat(Imation (United States)), Moji Ghadimi(The University of Queensland), Marta Alessi(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Shakeel Ahmed(University Hospital Kerry), Abdulrahman Al‐Fares(Amiri Hospital), Kate Ainscough, Ernita Akmal, Amal Abrous, Lara Absil, Qabas Alkhafajee, Angela Alberti(Northwell Health), Nathalie Allou, Kévin Alexandre, Jason D. Pole(Pediatric Oncology Group), Huda Alfoudri(Adan Hospital), Laura Merson, Jonathan S. Chávez-Íñiguez(Hospital Civil de Guadalajara), Razi Alalqam(University of Oxford), Tala Al-dabbous, Ryuzo Abe, Diana Adrião, Laurent Abel(Inserm), Chika Akwani, heryl Ann Abdukahil, Imran Ali, Tharwat Aisa, Andrew Acker, Kazali Enagnon Alidjnou, Jeffrey Aliudin, Eman Al Qasim
Cited by 21
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry
|The Lancet|2020|945
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
|The Journal of Experimental Medicine|2010|721